![Christopher Turner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Turner
Keine laufenden Positionen mehr
Profil
Christopher D.
Turner worked as Head-Clinical Research at ARIAD Pharmaceuticals, Inc. from 2008 to 2014.
From 2014 to 2018, served as Vice President-Clinical Science at Celldex Therapeutics, Inc. Between 2018 and 2021, held the position of Vice President-Clinical Development at Blueprint Medicines Corp.
Formerly held roles as Director-Pediatric Neuro Oncology Outcomes at Dana-Farber Cancer Institute, Inc. and Director-Pediatric Neuro Oncology Outcomes Clinic at The Children's Hospital Corp.
From 2021 to 2026, worked as Chief Medical Officer at Nuvalent, Inc. Education includes undergraduate studies at Bowdoin College and a doctorate from the University of Rochester School of Medicine & Dentistry.
Ehemalige bekannte Positionen von Christopher Turner
| Unternehmen | Position | Ende |
|---|---|---|
| NUVALENT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.07.2026 |
| BLUEPRINT MEDICINES CORPORATION | Corporate Officer/Principal | 01.03.2021 |
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | 01.05.2018 |
| ARIAD PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2014 |
The Children's Hospital Corp.
 The Children's Hospital Corp. Hospital/Nursing ManagementHealth Services Operates pediatric hospitals | Corporate Officer/Principal | - |
Ausbildung von Christopher Turner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital Corp.
The Children's Hospital Corp. Hospital/Nursing ManagementHealth Services Operates pediatric hospitals | Health Services |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
University of Rochester School of Medicine & Dentistry
 University of Rochester School of Medicine & Dentistry Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
